Loading...
XJPX3034
Market cap343mUSD
Jan 21, Last price  
1,429.00JPY
1D
0.56%
1Q
2.22%
Jan 2017
2.07%
IPO
397.48%
Name

Qol Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:3034 chart
P/E
10.96
P/S
0.30
EPS
130.35
Div Yield, %
2.24%
Shrs. gr., 5y
-0.63%
Rev. gr., 5y
4.46%
Revenues
180.05b
+5.89%
20,193,681,00021,701,982,00024,827,695,00038,002,105,00049,010,403,00056,305,532,00060,915,466,00066,201,592,00076,783,000,000100,966,000,000114,363,000,000124,957,000,000131,502,000,000145,516,000,000144,783,000,000165,411,000,000161,832,000,000166,199,000,000170,036,000,000180,052,000,000
Net income
4.88b
-13.72%
74,011,000333,325,000403,921,000547,369,000653,795,000828,439,0001,137,070,0001,560,198,0001,349,000,000777,000,0002,155,000,0003,641,000,0004,353,000,0004,986,000,0003,908,000,0004,067,000,0003,365,000,0005,489,000,0005,656,000,0004,880,000,000
CFO
13.53b
+16.04%
720,278,000-214,480,0001,003,710,0001,150,014,0002,213,259,0002,545,485,0002,233,070,0003,830,373,0005,327,000,0002,350,000,0007,841,000,0007,600,000,0005,813,000,00011,116,000,0005,773,000,0004,468,000,00012,912,000,00010,112,000,00011,662,000,00013,533,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Qol Holdings Co., Ltd., together with its subsidiaries, engages in dispensing pharmacy and business process outsourcing contracting businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also undertakes sales and marketing research activities for pharmaceutical companies; and provides temporary staff dispatch for pharmacists, nurses, registered sellers, registered dietitians, etc. In addition, the company offers clinical trial support services for pharmaceuticals and food products; support, monitoring, and technician dispatch services of managers for various processes, from planning of trial execution plans to monitoring, secretariat support, statistical analysis, and the presentation of conference papers; and publishing related services. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. Qol Holdings Co., Ltd. was founded in 1992 and is headquartered in Tokyo, Japan.
URL
https://www.qolhd.co.jp/
IPO date
Apr 21, 2006
Employees
5,746
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
180,052,000
5.89%
170,036,000
2.31%
166,199,000
2.70%
Cost of revenue
160,195,000
146,531,000
143,035,000
Unusual Expense (Income)
NOPBT
19,857,000
23,505,000
23,164,000
NOPBT Margin
11.03%
13.82%
13.94%
Operating Taxes
3,979,000
3,925,000
4,192,000
Tax Rate
20.04%
16.70%
18.10%
NOPAT
15,878,000
19,580,000
18,972,000
Net income
4,880,000
-13.72%
5,656,000
3.04%
5,489,000
63.12%
Dividends
(1,205,000)
(1,092,000)
(1,055,000)
Dividend yield
1.83%
2.54%
2.46%
Proceeds from repurchase of equity
330,000
9,178,000
6,237,000
BB yield
-0.50%
-21.38%
-14.56%
Debt
Debt current
8,155,000
8,712,000
8,722,000
Long-term debt
23,685,000
14,243,000
14,563,000
Deferred revenue
1,918,000
1,522,000
Other long-term liabilities
2,340,000
459,000
260,000
Net debt
(3,288,000)
(1,496,000)
1,023,000
Cash flow
Cash from operating activities
13,533,000
11,662,000
10,112,000
CAPEX
(2,072,000)
(4,510,000)
(1,732,000)
Cash from investing activities
(13,155,000)
(7,013,000)
(3,087,000)
Cash from financing activities
7,969,000
(2,569,000)
(10,006,000)
FCF
19,645,000
12,378,000
18,856,000
Balance
Cash
27,282,000
18,770,000
16,685,000
Long term investments
7,846,000
5,681,000
5,577,000
Excess cash
26,125,400
15,949,200
13,952,050
Stockholders' equity
43,864,000
88,995,000
79,463,000
Invested Capital
60,683,600
56,055,800
52,190,950
ROIC
27.20%
36.18%
35.60%
ROCE
22.80%
32.51%
34.86%
EV
Common stock shares outstanding
37,224
36,978
36,719
Price
1,767.00
52.20%
1,161.00
-0.51%
1,167.00
-25.00%
Market cap
65,774,191
53.21%
42,931,919
0.19%
42,850,936
-26.73%
EV
62,534,191
90,303,919
87,766,936
EBITDA
25,098,000
28,389,000
27,897,000
EV/EBITDA
2.49
3.18
3.15
Interest
109,000
89,000
101,000
Interest/NOPBT
0.55%
0.38%
0.44%